Jena Acquisition Corp II - 10-Q Summary (Q3 2025)
Business Context and Reporting Period
Jena Acquisition Corporation II (JENA) is a Cayman Islands exempted company and a Special Purpose Acquisition Company (SPAC) incorporated on February 24, 2025. The company is in the pre-business combination stage, with no operating revenue. Its sole purpose is to effect a merger, capital share exchange, or similar business combination. The reporting period covers the three months ended September 30, 2025, and the period from inception through September 30, 2025.
Key Financial Metrics
| Metric | Value |
|---|---|
| Trust Account Balance | $233,179,788 |
| Cash (Outside Trust) | $1,101,596 |
| Working Capital | $1,127,460 |
| Net Income (Q3 2025) | $2,286,119 |
| Net Loss (Inception to Q3 2025) | $(3,983,770) |
| Interest/Dividend Income (Q3 2025) | $2,418,248 |
| Operating Expenses (Q3 2025) | $132,129 |
| Deferred Underwriting Fee | $6,900,000 |
| Advisory Fee Payable | $6,900,000 |
| Shares Outstanding (Class A) | 23,225,000 (23,000,000 redeemable) |
| Shares Outstanding (Class B) | 5,750,000 |
Material Changes and Operational Highlights
- Initial Public Offering (IPO): Consummated on May 30, 2025, selling 23,000,000 Public Units at $10.00 per unit, generating gross proceeds of $230,000,000. The over-allotment option was fully exercised.
- Private Placement: Simultaneously with the IPO, the Sponsor purchased 225,000 Private Placement Units for $2,250,000.
- Trust Account Growth: The Trust Account balance increased from the initial $230,000,000 to $233,179,788 due to interest and dividend earnings of $3,179,788 since inception.
- Profitability: The company reported a net income of $2,286,119 for the quarter ended September 30, 2025, driven primarily by investment income ($2,418,248) which exceeded operating costs ($132,129). However, the company remains in an accumulated deficit of $(12,577,688) since inception due to the recognition of a $6,900,000 advisory fee expense.
Outlook, Risks, and Contingencies
- Combination Deadline: The company has until May 30, 2027 (24 months from IPO) to consummate a Business Combination. Failure to do so will result in liquidation and redemption of Public Shares.
- Liquidity: Management believes current cash and working capital are sufficient for operations for at least one year. No additional financing is currently anticipated, though Working Capital Loans up to $1,500,000 are available from the Sponsor if needed.
- Contingent Liabilities: Significant contingent liabilities include a $6,900,000 Deferred Underwriting Fee and a $6,900,000 Advisory Fee payable to Santander US Capital Markets LLC upon the completion of a Business Combination.
- Risks: As a SPAC, the company faces risks related to the inability to identify a suitable target, market conditions, and the potential for the Trust Account to be subject to creditor claims. The company is an emerging growth company and a shell company.
Investor Verification Checklist
- Trust Account Yield: Verify the current interest rate environment and its impact on the redemption value per share (currently approx. $10.14).
- Fee Structure: Confirm the total cost of the transaction, specifically the combined $13.8 million in deferred underwriting and advisory fees payable upon a successful merger.
- Redemption Rights: Review the specific terms regarding shareholder redemption rights and the potential dilution impact if a significant number of shares are redeemed.
- Sponsor Commitment: Verify the Sponsor's ability to satisfy indemnification obligations regarding third-party claims against the Trust Account, as the company notes the Sponsor's assets are primarily company securities.
- Extension Provisions: Check for any shareholder-approved extensions to the May 30, 2027 deadline, which would require additional capital contributions or amendments.